The Cancer Genome Atlas (TCGA) data analyses showed that the hepatic SPHK2 level was significantly increased in HCC as compared with normal livers, and it was further increased in extremely obese HCC patients (Suppl Fig. 1). This evidence concerns the gene SPHK2 and hepatocellular carcinoma.